Skip to main content

Cingulate Inc.

CINGW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001862150

No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.88K in total; no superinvestor holds it.

Other share classesCING

Q3 2022 vs. Q2 2022

How the institutions holding Cingulate Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CINGW: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders990
Shares2.22M2.29M+71.7K (+3.2%)
Value$561.0K$485.0K−$76.0K (−13.5%)

New holders (0)

Institutions that held Cingulate Inc. at the end of Q3 2022 but not at the end of Q2 2022.

None.

Sold out (0)

Institutions that held Cingulate Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

None.